Lessons from experiences of accessing healthcare during the pandemic for remobilizing rheumatology services: a national mixed methods study

Abstract Objectives To understand the impact of the coronavirus disease 2019 pandemic on access to healthcare services for patients with inflammatory and non-inflammatory musculoskeletal (MSK) conditions. Methods Three established cohorts that included individuals with axial SpA, psoriatic arthritis and MSK pain completed a questionnaire between July and December 2020. In parallel, a subset of individuals participated in semistructured interviews. Results A total of 1054 people (45% female, median age 59 years) were included in the quantitative analyses. Qualitative data included 447 free-text questionnaire responses and 23 interviews. A total of 57% of respondents had tried to access care since the start of the UK national lockdown. More than a quarter reported being unable to book any type of healthcare appointment. General practice appointments were less likely to be delayed or cancelled compared with hospital appointments. Younger age, unemployment/health-related retirement, DMARD therapy, anxiety or depression and being extremely clinically vulnerable were associated with a greater likelihood of attempting to access healthcare. People not in work, those reporting anxiety or depression and poorer quality of life were less likely to be satisfied with remotely delivered healthcare. Participants valued clear, timely and transparent care pathways across primary care and specialist services. While remote consultations were convenient for some, in-person appointments enabled physical assessment and facilitated the development and maintenance of clinical relationships with care providers. Conclusions We identified patient factors that predict access to and satisfaction with care and aspects of care that patients value. This is important to inform remobilisation of rheumatology services to better meet the needs of patients.

[1]  M. Limb Delayed discharge: how are services and patients being affected? , 2022, BMJ.

[2]  C. Gordon,et al.  Will ‘the feeling of abandonment’ remain? Persisting impacts of the COVID-19 pandemic on rheumatology patients and clinicians , 2022, Rheumatology.

[3]  H. Marzo-Ortega,et al.  Impact of COVID-19 containment measures on patients with rheumatic and musculoskeletal disease in the UK and Europe: the REUMAVID study (phase1) , 2021, Rheumatology advances in practice.

[4]  J. Newton,et al.  Inequalities in excess premature mortality in England during the COVID-19 pandemic: a cross-sectional analysis of cumulative excess mortality by area deprivation and ethnicity , 2021, BMJ Open.

[5]  C. Gordon,et al.  Telemedicine in rheumatology: a mixed methods study exploring acceptability, preferences and experiences among patients and clinicians , 2021, Rheumatology.

[6]  L. Trupin,et al.  Immediate effect of the COVID-19 pandemic on patient health, health-care use, and behaviours: results from an international survey of people with rheumatic diseases , 2021, The Lancet Rheumatology.

[7]  K. Oxtoby Covid-19: “Life on hold” for NHS patients needing musculoskeletal care , 2021, BMJ.

[8]  Joseph P. Wherton,et al.  Expanding Video Consultation Services at Pace and Scale in Scotland During the COVID-19 Pandemic: National Mixed Methods Case Study , 2021, Journal of medical Internet research.

[9]  F. Naughton,et al.  Impact of COVID-19 pandemic social restriction measures on people with rheumatic and musculoskeletal diseases in the UK: a mixed-methods study , 2021, BMJ Open.

[10]  G. Macfarlane,et al.  The BSR-PsA: study protocol for the British Society for Rheumatology psoriatic arthritis register , 2021, BMC Rheumatology.

[11]  M. Danila,et al.  Disruptions in Rheumatology Care and the Rise of Telehealth in Response to the COVID‐19 Pandemic in a Community Practice–Based Network , 2021, Arthritis care & research.

[12]  G. Macfarlane,et al.  The effect of COVID-19 public health restrictions on the health of people with musculoskeletal conditions and symptoms: the CONTAIN study , 2021, Rheumatology.

[13]  L. Carmona,et al.  Assessment of impact of the COVID-19 pandemic from the perspective of patients with rheumatic and musculoskeletal diseases in Europe: results from the REUMAVID study (phase 1) , 2021, RMD Open.

[14]  I. Scott,et al.  Impact of COVID-19 pandemic on utilisation of healthcare services: a systematic review , 2021, BMJ Open.

[15]  J. Bateman,et al.  Managing patients using telerheumatology: Lessons from a pandemic , 2021, Best Practice & Research Clinical Rheumatology.

[16]  C. Gordon,et al.  The impact of the COVID-19 pandemic on the medical care and health-care behaviour of patients with lupus and other systemic autoimmune diseases: a mixed methods longitudinal study , 2020, Rheumatology advances in practice.

[17]  P. Merkel,et al.  Concerns, Healthcare Use, and Treatment Interruptions in Patients With Common Autoimmune Rheumatic Diseases During the COVID-19 Pandemic , 2020, The Journal of Rheumatology.

[18]  A. Boonen,et al.  Influence of COVID-19 pandemic on decisions for the management of people with inflammatory rheumatic and musculoskeletal diseases: a survey among EULAR countries , 2020, Annals of the Rheumatic Diseases.

[19]  Devin M Mann,et al.  COVID-19 transforms health care through telemedicine: Evidence from the field , 2020, J. Am. Medical Informatics Assoc..

[20]  G. Macfarlane,et al.  Real-world evidence of TNF inhibition in axial spondyloarthritis: can we generalise the results from clinical trials? , 2020, Annals of the Rheumatic Diseases.

[21]  A. Ogdie,et al.  Experiences of Patients With Rheumatic Diseases in the United States During Early Days of the COVID‐19 Pandemic , 2020, ACR open rheumatology.

[22]  Virginia Braun,et al.  To saturate or not to saturate? Questioning data saturation as a useful concept for thematic analysis and sample-size rationales , 2019 .

[23]  G. Prescott,et al.  The Maintaining Musculoskeletal Health (MAmMOTH) Study: Protocol for a randomised trial of cognitive behavioural therapy versus usual care for the prevention of chronic widespread pain , 2016, BMC Musculoskeletal Disorders.

[24]  G. Macfarlane,et al.  The British Society for Rheumatology Biologics Registers in Ankylosing Spondylitis (BSRBR-AS) study: Protocol for a prospective cohort study of the long-term safety and quality of life outcomes of biologic treatment , 2015, BMC Musculoskeletal Disorders.

[25]  M. Englund,et al.  Trends in the first decade of 21st century healthcare utilisation in a rheumatoid arthritis cohort compared with the general population , 2012, Annals of the rheumatic diseases.

[26]  G. Bonsel,et al.  Development and preliminary testing of the new five-level version of EQ-5D (EQ-5D-5L) , 2011, Quality of Life Research.

[27]  J. Gafaranga,et al.  Comparison of face-to-face and telephone consultations in primary care: qualitative analysis. , 2010, The British journal of general practice : the journal of the Royal College of General Practitioners.

[28]  R. Hays,et al.  Development of physical and mental health summary scores from the patient-reported outcomes measurement information system (PROMIS) global items , 2009, Quality of Life Research.

[29]  W. Warburton,et al.  Understanding and sustaining the health care service shifts accelerated by COVID-19 , 2020 .